Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nasal carbon dioxide (CO2) for nasal congestion in perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Nasal carbon dioxide (CO2) therapy (carbon dioxide)

Snippet

Sponsor: Capnia, Inc. | Conditions: Perennial Allergic Rhinitis | Phase 2 | Status: COMPLETED